共 13 条
[1]
Cutler J.A., Macmahon S.W., Furberg C.D., Controlled clinical trials of drug treatment for hypertension. A review, Hypertension, 13, (1989)
[2]
Pollare T., Lithell H., Berne C., A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension, N Engl J Med, 321, pp. 868-873, (1989)
[3]
McVeigh G., Galloway D., Johnston D., The case for low dose diuretics in hypertension: Comparison of low and conventional doses of cyclopenthiazide, Br Medj, 297, pp. 95-98, (1988)
[4]
Carlsen J.E., Kober L., Torp-Pedersen C., Johansen P., Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects, Br Med J, 300, pp. 975-978, (1990)
[5]
Cranston W.I., Juel-Jensen B.E., Semmence A.M., Et al., Effects of oral diuretics on raised arterial pressure, Lancet, 2, pp. 966-970, (1963)
[6]
Kaplan N.M., Clinical Hypertension, (1990)
[7]
Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response, JAMA, 248, pp. 1996-2003, (1982)
[8]
Freis E.D., Age and antihypertensive drugs (Hydrochlorothiazide, bendroflumethiazide, nadolol, and captopril), Am J Cardiol, 61, pp. 117-121, (1988)
[9]
Burris J.F., Weir M.R., Oparil S., Et al., An assessment of diltiazem and hydrochlorothiazide in hypertension, JAMA, 263, pp. 1507-1512, (1990)
[10]
Navar L., Bell P.D., Burke T.J., Role of a macula densa feedback mechanism as a mediator of renal autoregulation, Kidney Int, 22, pp. S157-S164, (1982)